TRASGU Calculator | Applicability criteria

Applicability criteria for the model

Patients should meet all of the following eligibility criteria:

Patients with confirmed histological diagnosis of neuroendocrine tumor of the pancreas, esophagus, stomach, small intestine, appendix, colon, rectum, or unknown primary

TNM stage IV with documented, unresectable and metastatic disease measurable by computed tomography (CT)

Well-differentiated (G1/G2) tumors according to WHO classification

Ki-67≤20%

The patient is about to start monotherapy with somatostatin analogues (Sandostatin LAR or Lanreotide Autogel), with antiproliferative objective, with the intention of holding it until progression

Absence of potentially curable metastases

No other synchronous metastatic malignancy

Ok, go ahead Not eligible